Clinical trial · Interventional
Augmented Virtual Reality for Reducing Pain, Stress, Anxiety and Improve Self Efficacy in Adult Cancer Patients Undergoing Chemotherapy in The West Bank
The Effect of Using Augmented Virtual Reality on Pain, Stress, Anxiety, and Self-Efficacy Among Adult Cancer Patients Undergoing Chemotherapy in the West Bank
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The main purpose of this study is to examine the effect of using AVR on pain, stress, anxiety, and SE among adult cancer patients undergoing chemotherapy in the West Bank hospitals in Palestine. The main questions it aims to answer are: 1. What is the effect of AVR therapy on pain levels score compared with routine care during chemotherapy session among cancer patients? 2. What is the effect of AVR therapy on the stress levels compared with routine care during chemotherapy session among cancer patients? 3. What is the effect of AVR therapy on the anxiety compared with routine care during chemotherapy session among cancer patients? 4. What is the effect of AVR therapy on the general SE compared with routine care during chemotherapy session among cancer patients? The participants divided into two groups, the intervention group, which receives AVR, and the control group, which receives standard treatment. The study used a pretest and posttest design to assess the effect of AVR on the study variables (pain, stress, anxiety and self-efficacy).
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer and Chemotherapy Related Anemia | — | UNRESOLVED | — |
| Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma) | Malignant Neoplasm | ALIAS | 0.85 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| AVR Group (Chemotherapy + AVR) | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- NO_INTERVENTION
- label
- Control Group (Standard Chemotherapy Care)
- description
- the control group participated in routine sessions without AVR. Patients were admitted to the daycare unit, where a cannula was applied. The nurse then followed the doctor's order for the type of medication that would be given to the patient. Subsequently, the patients filled out the questionnaire at the posttest.
- type
- EXPERIMENTAL
- label
- AVR Group
- description
- Patients receive standard chemotherapy care plus Augmented Virtual Reality (AVR) distraction sessions during chemotherapy infusion.
- interventionNames
- Behavioral: AVR Group (Chemotherapy + AVR)
Primary outcomes (1)
- measure
- Change in pain intensity during chemotherapy
- timeFrame
- Immediately before chemotherapy and immediately after the session (June 2023 - September 2023).
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 60 Years
Show eligibility criteria text
Inclusion Criteria: 1. Adult patients aged 18-60 years undergoing chemotherapy for breast or colon cancer. 2. Stage I or II cancer, as defined by the study protocol. 3. Manageable levels of pain, anxiety, and stress, appropriate for participation in the intervention. \- Exclusion Criteria: 1. Age over 60 years. 2. Cancer types other than breast or colon cancer. 3. Severe pain, anxiety, or stress that could interfere with participation or require intensive care beyond the study scope.
References
Publications (0)
Data not yet available